Antibody therapy for modulating function of intestinal receptors and methods of treating diabetes and obesity

作者: Barbara S. Fox

DOI:

关键词:

摘要: The present invention provides pharmaceutical compositions formulated for direct delivery to the GI tract of a patient comprising an antibody specific target apical intestinal receptor. further methods treating diseases and conditions in administering directly patient, wherein modulation receptor by treats condition.

参考文章(38)
John E. Butler, Marcus E. Kehrli, Immunoglobulins and Immunocytes in the Mammary Gland and Its Secretions Mucosal Immunology. pp. 1763- 1793 ,(2005) , 10.1016/B978-012491543-5/50107-8
K. Masuda, K. Kato, H. Kim, C. Matsunaga, Y. Arata, K. Yamamoto, N. Takahashi, Y. Yamaguchi, T. Irimura, O-glycosylation in hinge region of mouse immunoglobulin G2b. Journal of Biological Chemistry. ,vol. 269, pp. 12345- 12350 ,(1994) , 10.1016/S0021-9258(17)32722-9
Soraya Shirazi-Beechey, Jane Dyer, Intestinal epithelial glucose sensor ,(2005)
Maurice Zauderer, Alena Donda, Jean-Pierre Mach, Bruno Robert, Valerie Cesson, Targeted cd1d molecules ,(2003)
R. Benamouzig, S. Mahe, J. Rautureau, H. Sick, D. Tome, Nils Roos, 15N-Labeled Immunoglobulins from Bovine Colostrum Are Partially Resistant to Digestion in Human Intestine Journal of Nutrition. ,vol. 125, pp. 1238- 1244 ,(1995) , 10.1093/JN/125.5.1238